PANAXIA LABS ISRAEL LTD Inactive Instrument
Company Panaxia Labs Israel Ltd TEL AVIV STOCK EXCHANGE
Equities
PNAX
IL0011043630
Investment Management & Fund Operators
Business Summary
Sales per Business
| ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Medical Cannabis Products
97.6
%
| 37 | 94.4 % | 19 | 97.6 % | -48.65% |
Production Services, Storage and Distribution
2.4
%
| 2 | 5.6 % | 0 | 2.4 % | -78.38% |
Sales per region
| ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Israel
53.8
%
| 27 | 67.3 % | 11 | 53.8 % | -60.25% |
Europe
46.2
%
| 13 | 32.7 % | 9 | 46.2 % | -29.84% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 19-09-30 |
Assi Rotbart
CHM | Chairman | 49 | 19-09-30 |
| Director of Finance/CFO | 66 | 22-12-27 | |
Eran Goldberg
CTO | Chief Tech/Sci/R&D Officer | 49 | 19-09-30 |
Joseph Ginossar
AUD | Comptroller/Controller/Auditor | 65 | 18-05-26 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 54 | 21-12-28 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 16-07-20 |
Michal Sapir
BRD | Director/Board Member | 66 | 22-03-16 |
Rinat Gazit
BRD | Director/Board Member | 55 | 19-10-30 |
Assi Rotbart
CHM | Chairman | 49 | 19-09-30 |
Dadi Segal
CEO | Chief Executive Officer | 48 | 19-09-30 |
Rinat Gazit
BRD | Director/Board Member | 60 | 19-09-30 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 430,240 | 192,660 ( 44.78 %) | 0 | 44.78 % |
Company contact information
Sector
Sales per Business
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| +38.76% | 102B | |
| +1.11% | 100B | |
| +22.75% | 29.13B | |
| -7.61% | 17.8B | |
| +8.31% | 15.86B | |
| +7.71% | 14.81B | |
| -22.02% | 12.22B | |
| +30.88% | 10.72B | |
| +19.53% | 9.27B |
